Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 3/20 | 0.50 |
| ▸ | CASR | P41180 | 4/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.46 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.43 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18320847 | 1.00 | AOC3 (0.50) | AOC3CASRL3MBTL1TAAR1MTNR1A | |
| SCHEMBL11618270 | 0.91 | AOC3 (0.51) | AOC3CASRL3MBTL1TAAR1MTNR1A | |
| SCHEMBL16871059 | 0.88 | CASR (0.48) | AOC3CASRL3MBTL1TAAR1 | |
| SCHEMBL16871396 | 0.88 | CASR (0.48) | AOC3CASRL3MBTL1TAAR1 | |
| SCHEMBL12463283 | 0.86 | AOC3 (0.48) | AOC3CASRL3MBTL1TAAR1MTNR1A | |
| SCHEMBL15121380 | 0.86 | AOC3 (0.53) | AOC3CASRL3MBTL1TAAR1MTNR1A | |
| SCHEMBL2322739 | 0.86 | CASR (0.47) | AOC3CASRL3MBTL1TAAR1MTNR1A | |
| SCHEMBL7412592 | 0.84 | TAAR1 (0.56) | AOC3CASRL3MBTL1TAAR1 | |
| SCHEMBL27536288 | 0.84 | AOC3 (0.49) | AOC3CASRL3MBTL1TAAR1ACHE | |
| SCHEMBL2177637 | 0.83 | CASR (0.44) | AOC3CASRL3MBTL1TAAR1MTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2519100-B1 | INTERMEDIATE COMPOUNDS AND PROCESSES FOR THE PREPARATION OF TAPENTADOL AND RELATED COMPOUNDS | MAPI PHARMA LTD (IL) | 2017-03-15 | — | — | EP | disclosed |
| US-9586914-B2 | Modulators of C3a receptors | THE UNIVERSITY OF QUEENSLAND (AU) | 2017-03-07 | — | — | US | disclosed |
| US-9550742-B2 | 11-OXO-10,11-dihydrodibenzo[B,F][1,4]thiazepine S-oxide derivatives and their use as dopamine D2 receptor antagonists | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2017-01-24 | — | — | US | disclosed |